Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.850
-0.040 (-2.12%)
At close: Apr 28, 2026, 4:00 PM EDT
1.850
0.00 (0.00%)
Pre-market: Apr 29, 2026, 8:01 AM EDT
Annovis Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 19.53 | 10.55 | 5.75 | 28.38 | 45.69 | |
| Cash & Short-Term Investments | 19.53 | 10.55 | 5.75 | 28.38 | 45.69 | |
| Cash Growth | 85.11% | 83.36% | -79.72% | -37.89% | 465.79% | |
| Prepaid Expenses | 0.34 | 0.37 | 0.04 | 0.1 | 0.07 | |
| Other Current Assets | 1.21 | 3.01 | 4.41 | 7.54 | 0.24 | |
| Total Current Assets | 21.08 | 13.93 | 10.21 | 36.02 | 46 | |
| Accounts Payable | 2.59 | 2.31 | 1.29 | 3.96 | 0.69 | |
| Accrued Expenses | 1.04 | 1.58 | 2.99 | 3.74 | 0.82 | |
| Total Current Liabilities | 3.64 | 3.88 | 4.28 | 7.7 | 1.51 | |
| Other Long-Term Liabilities | 0.6 | 0.74 | 13.68 | - | - | |
| Common Stock | 0 | 0 | 0 | 0 | 0 | |
| Additional Paid-In Capital | 180.55 | 144.16 | 102.51 | 82.38 | 73.22 | |
| Retained Earnings | -163.7 | -134.85 | -110.26 | -54.05 | -28.73 | |
| Total Common Equity | 16.85 | 9.31 | -7.75 | 28.32 | 44.49 | |
| Total Liabilities & Equity | 21.08 | 13.93 | 10.21 | 36.02 | 46 | |
| Net Cash (Debt) | 19.53 | 10.55 | 5.75 | 28.38 | 45.69 | |
| Net Cash Growth | 85.11% | 83.36% | -79.72% | -37.89% | 465.79% | |
| Net Cash Per Share | 0.95 | 0.86 | 0.64 | 3.48 | 5.99 | |
| Filing Date Shares Outstanding | 28.36 | 19.49 | 11.01 | 8.22 | 8.16 | |
| Total Common Shares Outstanding | 27.2 | 14.14 | 10.52 | 8.16 | 8.1 | |
| Working Capital | 17.45 | 10.04 | 5.93 | 28.32 | 44.49 | |
| Book Value Per Share | 0.62 | 0.66 | -0.74 | 3.47 | 5.49 | |
| Tangible Book Value | 16.85 | 9.31 | -7.75 | 28.32 | 44.49 | |
| Tangible Book Value Per Share | 0.62 | 0.66 | -0.74 | 3.47 | 5.49 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.